Skip to main content
TipRanks
Go Ultimate75% OFF

Aridis Pharmaceuticals (ARDS) Financial Statements

203 Followers

Aridis Pharmaceuticals Financial Overview

Aridis Pharmaceuticals's market cap is currently $4.46K. The company's EPS TTM is $-0.23; its P/E ratio is 0.00; Aridis Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 22Mar 22Dec 20Mar 20Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Gross Profit$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Operating Income$ -29.99M$ -43.71M$ -22.40M$ -29.09M$ -24.12M
EBITDA$ -29.51M$ -43.00M$ -22.06M$ -28.75M$ -23.83M
Net Income$ -30.75M$ -42.28M$ -22.33M$ -29.68M$ -22.11M
Balance Sheet
Cash & Short-Term Investments$ 4.88M$ 19.99M$ 8.23M$ 20.90M$ 24.24M
Total Assets$ 14.70M$ 26.80M$ 15.12M$ 27.97M$ 31.61M
Total Debt$ 6.13M$ 5.98M$ 715.00K$ 0.00$ 0.00
Net Debt$ 1.25M$ -14.01M$ -7.52M$ -20.90M$ -24.24M
Total Liabilities$ 38.93M$ 40.91M$ 23.80M$ 24.33M$ 5.30M
Stockholders' Equity$ -24.23M$ -13.11M$ -8.68M$ 3.64M$ 26.31M
Cash Flow
Free Cash Flow$ -29.21M$ -23.47M$ -20.84M$ -8.33M$ -24.95M
Operating Cash Flow$ -29.13M$ -22.94M$ -20.48M$ -8.16M$ -24.27M
Investing Cash Flow$ -82.00K$ -530.00K$ -367.00K$ -174.00K$ -1.68M
Financing Cash Flow$ 14.78M$ 34.72M$ 8.68M$ 4.99M$ 25.09M

Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

-50M-25M025M-3600 %-2400 %-1200 %0 %EarningsProfit Margin201720182019202020212022RevenueEarningsProfit Margin

Aridis Pharmaceuticals Liabilities to Assets

015M30M45M0 %100 %200 %300 %LiabilitiesLiabilities to Assets201720182019202020212022AssetsLiabilitiesLiabilities to Assets

Aridis Pharmaceuticals Cash Flow

-40M-20M020M40M201720182019202020212022OperatingInvestingFinancing

Aridis Pharmaceuticals Forecast EPS vs Actual EPS

-0.6-0.5-0.4-0.3-0.2-0.100.1Q3 22Q4 22Q1 23Q2 23Q3 23Q1 24EPS EstimateBeatMiss